COVID-19 Mortality and Related Comorbidities in Hospitalized Patients in Bulgaria.
COVID-19
case fatality rate
comorbidity
incidence
multiple chronic conditions
pandemic
Journal
Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525
Informations de publication
Date de publication:
14 Aug 2022
14 Aug 2022
Historique:
received:
18
07
2022
revised:
10
08
2022
accepted:
12
08
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
27
8
2022
Statut:
epublish
Résumé
Until now, the COVID-19 pandemic has resulted in at least 27 million cases and over 900,000 deaths worldwide. Bulgaria is one of the countries that is the most severely affected by the COVID-19 pandemic, and the mortality rate is among the highest registered in the world. The aim of this study is to investigate and analyze mortality rates due to the fact of COVID-19 in addition to the most common related underlying medical conditions in those hospitalized to outline the factors that have an impact on the mortality rate due to the fact of COVID-19. A descriptive cross-sectional research design with a retrospective analysis was used to collect data from a total of 128,269 hospitalized patients during the period from April 2020 to November 2021. During the study period, the number of hospital admissions due to the fact of COVID-19 was 5200. The patients' mean age was 67.34 (SD ± 19.65), and 51.7% (2689) of the patients were men. Only 10% of out of a total of 5200 patients did not test positive for COVID-19 upon admission based on the antigen or PCR test. Out of all patients, 41.5% had no underlying medical conditions upon presentation, and the remaining 58.5% had diagnosed comorbidities, varying from one to five. One-third (1470) had a lethal outcome, and the remaining 71.7% recovered from the infection and were discharged from the hospital. Based on the analysis of our results, there is definite evidence that the CFR and susceptibility to symptomatic COVID-19 were higher in the elderly, men, and patients with more comorbidities, especially chronic cardiovascular, metabolic, and respiratory disorders, as well as in those admitted to hospital within 6 h after an emergency ward visit and who had a shorter mean hospital stay.
Identifiants
pubmed: 36011192
pii: healthcare10081535
doi: 10.3390/healthcare10081535
pmc: PMC9407837
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Prev Med Hyg. 2021 Jul 30;62(2):E311-E320
pubmed: 34604571
Lancet Glob Health. 2021 Jan;9(1):e14-e15
pubmed: 33160453
Osong Public Health Res Perspect. 2020 Apr;11(2):74-80
pubmed: 32257772
Med Pr. 2021 Dec 22;72(6):671-676
pubmed: 34751682
BMC Med. 2020 Sep 3;18(1):270
pubmed: 32878619
Cytokine Growth Factor Rev. 2020 Jun;53:33-37
pubmed: 32389499
Clin Infect Dis. 2000 Aug;31(2):578-85
pubmed: 10987724
Nat Rev Immunol. 2020 Jun;20(6):363-374
pubmed: 32346093
Front Public Health. 2020 Apr 29;8:152
pubmed: 32411652
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
J Med Virol. 2020 Oct;92(10):1875-1883
pubmed: 32441789
Travel Med Infect Dis. 2020 Mar - Apr;34:101623
pubmed: 32179124
Prev Chronic Dis. 2020 Jul 16;17:E63
pubmed: 32678061
Infect Chemother. 2020 Jun;52(2):154-164
pubmed: 32537961
JACC Case Rep. 2020 Jul 15;2(9):1407-1410
pubmed: 32373791
MMWR Morb Mortal Wkly Rep. 2021 Sep 17;70(37):1284-1290
pubmed: 34529637
Int J Infect Dis. 2020 May;94:91-95
pubmed: 32173574
Eur J Heart Fail. 2020 May;22(5):911-915
pubmed: 32275347